This page is part of the FHIR Specification v6.0.0-ballot4: Release 6 Ballot (1st Full Ballot) (see Ballot Notes). The current version is 5.0.0. For a full list of available versions, see the Directory of published versions for published versions
| Responsible Owner: Biomedical Research and Regulation Work Group | Standards Status: Informative | Compartments: No defined compartments |
This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile Substance.
Generated Narrative: Substance f205
category: Drug or Medicament
| Concept |
| Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
description:
Augmentin 875
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.